Published in Clin Sci Mol Med on June 01, 1974
Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. J Clin Invest (1989) 1.14
Regulation of lipoprotein lipase in primary cultures of isolated human adipocytes. J Clin Invest (1985) 0.98
Regulation of lipoprotein lipase immunoreactive mass in isolated human adipocytes. J Clin Invest (1988) 0.95
High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med (1992) 1.66
Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia (2000) 1.54
Effect of oestrogens on human platelet behaviour. Lancet (1968) 1.49
The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diabetes Care (1998) 1.28
Effect of treatment of hyperlipidaemia on haemostatic variables. Br Med J (1980) 1.20
Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol. Clin Sci (Lond) (1983) 1.18
Factors predisposing to and outcome of gestational diabetes. Obstet Gynecol (1989) 1.10
Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis (2001) 1.06
Hypoglycaemia in an inner-city accident and emergency department: a 12-month survey. Arch Emerg Med (1989) 1.04
Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers. Br Med J (Clin Res Ed) (1987) 1.03
Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention. Diabet Med (1988) 1.00
The effect of diet and insulin on metabolic profiles of women with gestational diabetes mellitus. Diabetes (1985) 0.99
The effect of heparin in vitro on human plasm post-heparin lipolytic activity. Clin Chim Acta (1975) 0.95
Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care (2000) 0.93
Effect of a pyrimido-pyrimidine compound on platelet behaviour in vitro and in vivo. Lancet (1968) 0.92
The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med (1991) 0.90
Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care (2001) 0.90
Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects. J Hum Hypertens (1990) 0.89
Effect of treatment of hypertriglyceridaemia on high and low density lipoprotein cholesterol concentrations. Lancet (1979) 0.87
High-density lipoprotein composition and paraoxonase activity in Type I diabetes. Clin Sci (Lond) (2001) 0.87
Evidence for an hepatic anti-ketogenic effect of insulin in man. Clin Sci Mol Med (1978) 0.86
Calorie restriction for treatment of gestational diabetes. Diabetes (1991) 0.85
Beta-blockers, lipoproteins and non-insulin dependent diabetes. Postgrad Med J (1988) 0.85
Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. Diabet Med (2003) 0.84
Heroin and hyperkalaemia. Lancet (1981) 0.84
The effect of insulin on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate concentrations in human plasma. Clin Sci Mol Med (1976) 0.84
Serum-insulin in acromegaly. Lancet (1969) 0.83
The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabet Med (1988) 0.82
Lipids in non-insulin dependent diabetes: a case for treatment? J R Soc Med (1991) 0.82
Arterial wall changes in type 2 diabetic subjects. Diabet Med (1994) 0.82
Total antioxidant status, protein glycation, lipid hydroperoxides in non insulin dependent diabetes mellitus. Biochem Soc Trans (1997) 0.81
Abnormalities of glucose tolerance following gestational diabetes. Q J Med (1990) 0.81
Can protein biomarkers provide an index of coronary artery calcification in patients with Type 2 diabetes? Atherosclerosis (2010) 0.81
Prostaglandin E 1 and human platelets. Lancet (1969) 0.81
Lipid modification and coronary heart disease in type 2 diabetes: different from the general population? Heart (1999) 0.81
Hepatic and lipoprotein lipases selectively assayed in postheparin plasma. Clin Chem (1993) 0.80
Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes. Diabet Med (2002) 0.80
High density lipoproteins, diabetes and diabetic macrovascular disease. Diabet Med (1985) 0.80
Correlation between carotid artery distensibility and serum vascular endothelial growth factor concentrations in type 1 diabetic subjects and nondiabetic subjects. Metabolism (2001) 0.79
Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease. Clin Sci Mol Med (1975) 0.79
Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study. Diabet Med (2006) 0.78
The relationship between active renin concentration and plasma renin activity in Type 1 diabetes. Diabet Med (2001) 0.78
Diabetic hypertension--the importance of fibrinogen and blood viscosity. J Hum Hypertens (1988) 0.78
The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia (1978) 0.78
The effect of hypolipidaemic therapy on serum uric acid concentration. Atherosclerosis (1976) 0.78
The effects of fasting and streptozotocin diabetes on hepatic triglyceride lipase activity in the rat. Diabetes (1977) 0.78
Analysis of high density lipoprotein subclasses by a precipitation procedure: comparison with preparative ultracentrifuge. Clin Chim Acta (1982) 0.77
Serum insulin, glucose, and lipid levels among mild diabetics in relation to incidence of vascular complications. Lancet (1971) 0.77
Aspects of metabolism in normal and gestational diabetic pregnancy. Biochem Soc Trans (1995) 0.77
Hypertriglyceridaemia and hyperuricaemia. Lancet (1977) 0.77
Treatment of diabetes: the effect on serum lipids and lipoproteins. Postgrad Med J (1991) 0.77
Chlorpropamide lowers serum and lipoprotein cholesterol in insulin-dependent diabetes. Diabet Med (1986) 0.76
Feedback inhibition of insulin secretion in type 2 diabetes. Clin Sci (Lond) (1991) 0.76
Determinants of mild fasting hypertriglyceridaemia in non-insulin-dependent diabetes. J Intern Med (1991) 0.76
Reduced postprandial energy expenditure in women predisposed to type 2 diabetes. Diabet Med (1994) 0.76
Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes. Clin Endocrinol (Oxf) (1991) 0.76
Regulation of hepatic lipase expression in HepG2 cells. Biochem Soc Trans (1997) 0.76
The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy. J R Soc Med (1989) 0.76
A defect in insulin release in women at risk of future non-insulin-dependent diabetes. Clin Sci (Lond) (1991) 0.76
Serum lipids and apolipoproteins and their relationship with macrovascular disease in type 1 diabetes. Diabet Med (1994) 0.76
Ethnic differences in insulin secretion in women at risk of future diabetes. Diabet Med (1992) 0.76
Blood glucose and coronary heart disease. Eur Heart J (2000) 0.75
Insulin resistance, cardiovascular risk factors and ultrasonically measured early arterial disease in normotensive Type 2 diabetic subjects. Diabetes Metab Res Rev (2001) 0.75
The effect of CI-719 on lipolysis in rat adipose tissue. Proc R Soc Med (1976) 0.75
Hypertriglyceridaemia and abdominal pain. Br Med J (1976) 0.75
Solitary pancreas transplantation. Diabetologia (1997) 0.75
Insulin and atheroma. Lancet (1969) 0.75
Haemoglobin A1, blood glucose, and high-density lipoprotein cholesterol in insulin-requiring diabetics. Lancet (1978) 0.75
Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes. J Hum Hypertens (1988) 0.75
The secretion of thyrotrophin with impaired biological activity in patients with hypothalamic-pituitary disease. Clin Endocrinol (Oxf) (1978) 0.75
The value of screening for diabetes in patients with skin sepsis. J R Soc Med (1993) 0.75
The effect of treatment of non-insulin-dependent diabetes mellitus (NIDDM) on serum lipids and lipoproteins. Q J Med (1989) 0.75
Type 1 diabetes and ageing: does LDL oxidation mediate their associations with coronary heart disease? Eur Heart J (2001) 0.75
Attitude of consultant physicians to Calman proposals. Anxieties are widespread. BMJ (1996) 0.75
The direct effect of oral hypoglycaemic agents on glucose metabolism by adipose tissue. Horm Metab Res (1972) 0.75
Diabetes and therapy with potent diuretics. Lancet (1978) 0.75
The role of heparin in lipoprotein lipase activity. Horm Metab Res (1974) 0.75
Hepatic abscess in a diabetic patient. Postgrad Med J (2000) 0.75
Insulin, glucose and lipid levels in mild diabetics in relation to complications. Adv Metab Disord (1973) 0.75
Diabetic macrovascular disease and serum lipids: is there a connection? Diabet Med (1992) 0.75
Comparison of the progress of flat new vessels on the optic disc with those on the retina in patients treated by pituitary ablation. Diabetologia (1971) 0.75
The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion. Diabetes Care (1983) 0.75
Proceedings: Plasma cyclic AMP response to glucagon in thyroid disease. Clin Sci Mol Med (1974) 0.75
Bimonthly update. Therapy and clinical trials. Curr Opin Lipidol (2000) 0.75
Glucagon resistance as a case of hypertriglyceridaemia. Lancet (1976) 0.75
The response of hepatic lipase and serum lipoproteins to acute hyperinsulinaemia in type 2 diabetes. Eur J Clin Invest (1992) 0.75
Necrobiosis lipoidica in two diabetic sisters. Clin Exp Dermatol (1985) 0.75
Therapy and clinical trials. Curr Opin Lipidol (1998) 0.75
The effect of insulin treatment on the metabolic response to glucagon in diabetes. Diabete Metab (1977) 0.75
Post-heparin lipolytic activity and tissue lipoprotein lipase activity in the alloxan-diabetic rat. Clin Sci Mol Med (1974) 0.75
High density lipoprotein subfraction cholesterol in hypertriglyceridaemia. Atherosclerosis (1982) 0.75
Therapy and clinical trials. Curr Opin Lipidol (1999) 0.75
Long term improvement in dyslipidaemia in Type 2 diabetes with bezafibrate is not related to changes in insulin resistance. Atherosclerosis (1999) 0.75
The contribution of hepatic triglyceride lipase to plasma post-heparin lipolytic activity in the rat. Horm Metab Res (1977) 0.75
Effect of storage on the precipitation procedure for the measurement of HDL subclasses in serum. Clin Chim Acta (1984) 0.75
Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone. Diabete Metab (1978) 0.75
Comparison between oral and intravenous fat tolerance tests in normolipidaemic subjects. Horm Metab Res (1988) 0.75
Lipoprotein lipase in human adipose tissue. Clin Sci (1973) 0.75
Association of high density lipoprotein cholesterol with plasma lipolytic activity and C-peptide concentration in type 2 diabetes. Diabetes Res (1991) 0.75